Understanding HS Codes for Pharmaceutical Exports from India
Chapter 30 covers finished pharmaceutical products; Chapter 29 covers the APIs. Here's how the classification actually works and why it matters for every quotation.
Customs classification under the Harmonized System determines duty, export-incentive eligibility, and — critically — whether a current DGFT export restriction applies to a specific product. Getting the 8-digit code right against the official DGFT ITC(HS) lookup, rather than a generic blog reference, is a basic diligence step on every quotation.
The headings that matter most
- 3001 — Glands, organs and human/animal-derived substances (e.g. heparin)
- 3002 — Vaccines, antisera, biologicals, diagnostic reagents
- 3003 / 3004 — Medicaments in bulk (3003) or measured retail doses (3004) — the main heading for finished formulations, split into sub-headings by therapeutic class
- 3005 / 3006 — Dressings, sutures, contraceptives, dental materials and similar device-classified goods
- 2933 / 2934 / 2941 — The organic-chemistry headings covering the bulk of small-molecule and antibiotic APIs
- 1302 / 3003.90 — Ayurvedic and herbal extracts, often classified outside the standard medicament headings
- 2106.90 — Food preparations, which is usually the correct heading for nutraceuticals and food supplements, not Chapter 30
- 9018 / 9021 / 9022 — Medical instruments, orthopaedic appliances and diagnostic imaging apparatus
Why this changes your regulatory burden, not just your duty rate
A product's HS heading often signals which regulatory regime governs it. Nutraceuticals classified under 2106.90 face a food-supplement pathway rather than drug registration; dental materials under 3006.40 are regulated as devices rather than medicines in most markets. Confirming the correct heading early avoids assuming the wrong regulatory pathway for a product.